Cystic Fibrosis Newswire

Cystic Fibrosis Newswire

Comprehensive Real-Time News Feed for Cystic Fibrosis.

Results 1 - 20 of 929 in Cystic Fibrosis

  1. Vertex Looks Attractive With New Positive Data, Acquisition BuzzRead the original story w/Photo

    Monday | Seeking Alpha

    Vertex Pharmaceuticals Inc. develops therapies for serious and orphan diseases. It particularly focuses on the Cystic Fibrosis market, where it has already carved a niche.

    Comment?

  2. Global Cystic Fibrosis Therapeutics Market 2016-2022: Profiles of Key ...Read the original story w/Photo

    Monday | PR Newswire

    The report provides an in-depth analysis of all the major segments, taking into account the major developments taking place at global level in the respective segments that will further boost the growth of cystic fibrosis therapeutics market. The Global Cystic Fibrosis Therapeutics industry has reported a tremendous growth in the recent years, and is presenting ample opportunities to the industry players.

    Comment?

  3. Snixfest 2017 features several bands throughout day and nightRead the original story w/Photo

    Saturday Jul 22 | RiverBender.com

    ... years Snixfest has donated proceeds to organizations like the 5As, the Tree House Wildlife Center and the Cystic Fibrosis Foundation. "We've raise lots of money in the past for lots of things," Davenport said. "And this year should be no different." ...

    Comment?

  4. Marshwood High School track is resurfacedRead the original story w/Photo

    Friday Jul 21 | Foster's Daily Democrat

    ... members use it for running and walking. Walk-a-thons are held to raise funds for non-profits like the Cystic Fibrosis Foundation. National Guard personnel from the Pease Air National Guard Base and Marines from the Portsmouth Naval Shipyard use the ...

    Comment?

  5. U.S. stocks hit record highsRead the original story w/Photo

    Wednesday Jul 19 | Reuters

    ... the advance of the major indices." Vertex Pharmaceuticals jumped after it reported positive results for its cystic fibrosis treatment. Morgan Stanley rose following better-than-expected profit and only modest decline in bond trading revenue. ...

    Comment?

  6. Wall Street sets records, iron ore surge to boost Australian minersRead the original story w/Photo

    Wednesday Jul 19 | ABC News

    ... which surged 26.4 per cent to $US160.67 per share. This was after Vertex reported positive results for its cystic fibrosis treatments. On the flip-side, technology giant IBM were a drag on the Dow - its share price was down 4.4 per cent after ...

    Comment?

  7. Stocks Rise as S&P 500, Nasdaq Top Records AgainRead the original story w/Photo

    Wednesday Jul 19 | News Max

    ... Pharmaceuticals Inc. led gainers, adding more than 20 percent after reporting promising results for its cystic fibrosis treatment. Technology remained hot as well, with the Nasdaq 100 Index also reaching an all-time high. The Dow Jones Industrial ...

    Comment?

  8. New highs for Wall Street fueled by tech issuesRead the original story w/Photo

    Wednesday Jul 19 | Toledo Blade

    ... jumped as much as 26.4 percent to an all-time high of $167, a day after it reported positive results for its cystic fibrosis treatment. The stock ended up 20.8 percent at $159.69, and was the biggest boost on the S&P and the Nasdaq. IBM was a drag ...

    Comment?

  9. Earnings Boost Stocks, But IBM Holds Back the Dow: Markets WrapRead the original story

    Wednesday Jul 19 | The Washington Post

    ... Pharmaceuticals Inc. led gainers, rising more than 20 percent after reporting promising results for its cystic fibrosis treatment. Technology remained hot as well, with the Nasdaq 100 Index also reaching an all-time high. The Dow Jones Industrial ...

    Comment?

  10. Tech lifts Nasdaq, S&P to record; IBM weighs on DowRead the original story w/Photo

    Wednesday Jul 19 | Channelnewsasia.com

    ... jumped as much as 26.3percent to an all-time high after the company reported positive results for its cystic fibrosis treatment. The stock was the biggest boost on the S&P and the Nasdaq. Investors will continue to focus on quarterly earnings to see ...

    Comment?

  11. Vertex Growth Expected to Continue With Life-Changing Cystic Fibrosis TreatmentRead the original story w/Photo

    Wednesday Jul 19 | TheStreet.com

    Vertex Pharmaceuticals Inc. has popped by 21% through mid-day trading on July 19 on positive data for a promising new drug but analysts are forecasting that the Boston, Mass.-based company still has upside potential. Following the release of data from Vertex's triple regimen combination trials for cystic fibrosis, shares of Vertex surged to record highs, boosting its market capitalization by $8 billion.

    Comment?

  12. S&P 500, Nasdaq At All-time Highs After Opening GainsRead the original story w/Photo

    Wednesday Jul 19 | Fox News

    ... Inc. soared 23% after the drug company late Tuesday announced positive results from clinical studies of its cystic fibrosis treatments.

    Comment?

  13. Vertex Shares Haven't Hit Their ApexRead the original story w/Photo

    Wednesday Jul 19 | Wall Street Journal

    Investors in the biotechnology company hit the jackpot on Tuesday afternoon after it announced breakthrough results in early stage data for its new cystic fibrosis treatment.

    Comment?

  14. 'This is life-changing for these patients:' A biotech is skyrocketing ...Read the original story w/Photo

    Wednesday Jul 19 | Silicon Alley Insider

    In this March 4, 2015 photo, Viji Arumugam, a scientist at Vertex Pharmaceuticals Inc., works on test in her laboratory in San Diego Vertex Pharmaceuticals scored a major win Tuesday with the release of data from three clinical trials testing three different triple combinations of cystic fibrosis drugs. Patients genetically resistant to all treatments now on the market showed unprecedented gains in lung function on all three experimental therapies.

    Comment?

  15. Wall Street opens higherRead the original story

    Wednesday Jul 19 | The Standard

    Stocks are rising further in morning trading as health care companies, banks and consumer companies all gain ground. Vertex Pharmaceuticals surged by 25 percent today after it reported positive results from studies of a cystic fibrosis drug.

    Comment?

  16. S&P, Nasdaq extend intraday record highsRead the original story w/Photo

    Wednesday Jul 19 | Seeking Alpha

    ... r U.S. corporate news, and Vertex Pharma +25% after announcing positive results from clinical studies of its cystic fibrosis treatments. U.S. Treasurys trade flat following a bullish three-day run; the benchmark 10-year yield is unchanged at 2.26%.

    Comment?

  17. S&P 500, Nasdaq hit fresh records; Morgan Stanley leads banks higherRead the original story w/Photo

    Wednesday Jul 19 | MarketWatch

    ... soared 26% a day after the drug company late Tuesday announced positive results from clinical studies of its cystic fibrosis treatments.

    Comment?

  18. Triple Drug Combos Effective for Cystic Fibrosis: TrialsRead the original story w/Photo

    Wednesday Jul 19 | News Max

    Vertex Pharmaceuticals Inc on Tuesday said three different triple combinations of cystic fibrosis treatments significantly improved patient lung function in clinical trials, bolstering its goal of a therapy that could help up to 90 percent of patients with the life-shortening lung disease. Once it has analyzed additional data and discussed development plans with regulators, Vertex said it will begin late stage studies of one or more of the triple combination regimens in the first half of 2018.

    Comment?

  19. Block grants and breathingRead the original story

    Wednesday Jul 19 | Balloon Juice

    ... mixture or new technologies that are more effective and more costly than current best choice treatments. Cystic Fibrosis is a cluster of genetic mutations that makes breathing very difficult. Individuals with CF can't clear the mucus that coats ...

    Comment?

  20. Nasdaq, S&P Hit Record Highs as Tech, Health Stocks RiseRead the original story w/Photo

    Wednesday Jul 19 | The New York Times

    ... advancers. Vertex Pharmaceuticals jumped 25.6 percent after the company reported positive results for its cystic fibrosis treatment. The stock was the biggest boost on the S&P and the Nasdaq. Investors will continue to focus on quarterly earnings to ...

    Comment?